A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

  • Hacein-Bey-Abina S
  • von Kalle C
  • Schmidt M
  • et al.
1.7kCitations
Citations of this article
649Readers
Mendeley users who have this article in their library.
Get full text

Abstract

to the editor: We recently reported (April 18 issue) 1 the sustained correction of X-linked severe combined immunodeficiency disease by ex vivo, retrovirally mediated transfer of the gc gene into CD34+ cells in four of five patients with the disease. These results have since ...

Cite

CITATION STYLE

APA

Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., … Fischer, A. (2003). A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency. New England Journal of Medicine, 348(3), 255–256. https://doi.org/10.1056/nejm200301163480314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free